DLB - CIK 0001308547
The table below shows Dolby Laboratories, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $472.20M | $327.25M | $367.08M | $318.58M | $447.75M | $343.85M |
| Capital expenditure | $36.35M | $30.01M | $30.34M | $47.93M | $54.45M | $66.35M |
| Investing cash flow | -$10.59M | -$286.29M | $54.21M | -$295.94M | -$44.91M | $134.37M |
| Dividends paid | - | - | - | - | - | - |
Dolby Laboratories, Inc. reported operating cash flow of $472.20M for fiscal year 2025. That is up 44.3% from $327.25M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $360.06M (FY 2016) to $472.20M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $124.99M | $160.00M | $149.28M | $530.49M | $245.86M | $173.74M |
| Financing cash flow | -$247.24M | -$287.81M | -$236.81M | -$610.56M | -$252.51M | -$207.78M |